Flash e-reader

 Go to e-reader chapter








Table 12.12

Adjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,777 92.7% 0.5% 2,777 83.3% 0.7% 7,599 53.5% 0.8% 12,189 27.0% 0.8%
Primary Diagnosis Emphysema/COPD 801 93.6% 0.9% 801 84.8% 1.3% 2,500 55.7% 1.3% 4,473 24.6% 1.2%
Cystic Fibrosis 373 95.3% 1.4% 373 82.9% 2.8% 1,120 53.0% 2.3% 1,850 34.1% 2.0%
Idiopathic Pulmonary Fibrosis 950 92.8% 0.8% 950 83.2% 1.3% 2,213 52.7% 1.5% 2,989 25.2% 1.8%
Alpha-1-Antitrypsin Deficiency 78 97.5% 1.7% 78 91.4% 3.1% 293 61.5% 3.3% 655 28.0% 3.0%
Idiopathic Pulmonary Arterial Hypertension 48 85.4% 5.5% 48 80.6% 6.1% 182 49.0% 4.7% 380 36.0% 3.3%
Congenital Disease 2 + + 2 + + 19 41.4% 11.6% 79 34.7% 6.0%
Other 524 89.5% 1.4% 524 80.3% 1.8% 1,271 52.9% 1.9% 1,762 32.8% 2.1%
Unknown 1 + + 1 + + 1 + + 1 + +


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.